Three-dimensional ultrasound and three-dimensional power Doppler in the assessment of adnexal masses

Ultrasound Review of Obstetrics and Gynecology

Volumn 1, Issue 2, 2001, Pages 167-183

  Kurjak, A ^a   Sparac, V ^a   Kupesic, S ^a   Bekavac, I ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Adnexal masses; Angiogenesis; Three dimensional power Doppler; Three dimensional ultrasound

Indexed keywords

EID: 0041697807     PISSN: 14722240     EISSN: 17438950     Source Type: Journal    
DOI: 10.3109/14722240108500425     Document Type: Article

References (80)

1. Koonings PP, Campbell K, Mishell DR Jr, Grimes DA. Relative frequency of primary ovarian neoplasms: a ten-year review. Obstet Gynecol 1989; 74: 921 – 6
2. Kinkel K, Hricak H, Lu Y, Tsuda K, Filly R. Ultrasound characterization of ovarian masses: a meta-analysis. Radiology 2000; 217: 803 – 11
3. Warren BA. The vascular morphology of tumors. In Peterson HI, ed. Tumor Blood Circulation: Angiogenesis, Vascular Morphology and Blood Flow of Experimental Human Tumors. Boca Raton, FL: CRC Press, 1979: 1 – 47
4. Coman DR, Sheldon WF. The significance of hyper- emia aroundtumor implants. Am J Pathol 1946; 22: 821 – 6
5. Algire GH, Chalkley HW, Lagallais FY, Park HD. Vas- cular reactions of mice to wounds and to normal and neoplastic transplants. J Natl Cancer Inst 1945; 6: 73 – 85
6. Folkman J, Long D, Becker F. Growth andmetastasis of tumor in organ culture. Tumor Res 1963; 16: 453 – 67
7. Folkman J, Cole P, Zimmerman S. Tumor behaviour in isolatedperfusedorgans: in vitro growth andmetas- tasis of biopsy material in rabbit thyroidandcanine intestinal segment. Ann Surg 1966; 164: 491 – 502
8. Folkman J, Merler E, Abernathy C, Williams G. Isola- tion of a tumor factor responsible for angiogenesis. J Exp Med 1971; 133: 275 – 88
9. Klagsbrun M, D’Amore PA. Regulators of angio- genesis. Annu Rev Physiol 1991; 53: 217
10. Folkman J. What is the evidence that tumors are angiogenesis-dependent? J Natl Cancer Inst 1989; 82: 4 – 6
11. Auerbach R. Angiogenesis-inducing factors: a review. In Pick E, ed. Lymphokines, Vol. 4. London: Academic Press, 1981: 69 – 88
12. Rak JW, St Croix DB, Kerbel RS. Consequences of angiogenesis for tumor progression, metastasis and cancer therapy. Anti-Cancer Drugs 1995; 6: 3 – 18
13. Plate KH. From angiogenesis to lymphangiogenesis. Nature Med 2001; 7: 151 – 2
14. Skobe M, Rockwell P, Vosseler S, Fusenig NE. Halting angiogenesis suppresses carcinoma cell invasion. Nature Med 1997; 3: 1222 – 7
15. Gasparini G, Weidner N, Maluta S, et al. Intratumoral microvessel density and p53 correlation with metas- tasis in head-and-neck squamous-cell carcinoma. Int J Cancer 1993; 55: 739 – 44
16. Gasparini G, Weidner N, Bevilacqua P, et al. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carci- noma. J Clin Oncol 1994; 12: 454 – 66
17. Weidner N. Tumor angiogenesis: review of current applications in tumor prognostication. Semin Diagn Pathol 1993; 10: 302 – 13
18. Folkman J, Klagsburn M. Angiogenic factors. Science 1987; 2345: 442 – 7
19. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146: 1029 – 39
20. Plate KH, Breier G, Weich HA, Rissau W. Vascular endothelial growth factor is a potential tumor angio- genesis factor in human gliomas in vivo. Nature 1992; 359: 845 – 8
21. Kim KJ. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 1993; 362: 841 – 4
22. Lu JJ, Stanczyk FZ, Zeng W. Expression of VEGF in ovarian epithelial tumors. J Soc Gynecol Invest 2001; 8:766
23. Folkman J. Growth andmetastasis of tumor in organ culture. Cancer 1963; 16: 453 – 7
24. Guilino PM. Extracellular compartments of solid tumors. In Becker J, ed. Cancer. New York: Plenum Press, 1975:327
25. Jain RK. Determination of tumor bloodflow: a review. Cancer Res 1988; 48: 2641 – 6
26. Kurjak A, Kupesic S, Breyer B. The assessment of ovarian tumor angiogenesis by three-dimensional power Doppler. In Kurjak A, ed. Three-Dimensional Power Doppler in Obstetrics and Gynecology. Carnforth, UK: Pathenon Publishing, 2000: 19 – 34
27. Jain RK, Ward-Harley K. Tumor blood flow character- ization, modifications and role in hyperthermia. Trans Sonics Ultrasonics 1984; 31: 504 – 9
28. Vaupel P, Kallinowski F, Okunieff P. Bloodflow oxygen andnutrient supply, andmetabolic micro- environment of human tumors: a review. Cancer Res 1989; 49: 6449
29. Fleischer AC. Sonographic depiction of tumor vascularity andflow: from in vivo models to clinical applications. J Ultrasound Med 2000; 19: 55 – 61
30. Hanahan D, Folkman J. Parameters andemerging mechanisms of the angiogenetic switch during tumorigenesis. Cell 1996; 86: 353 – 4
31. Kurjak A, Kupesic S, Ilijas M, Sparac V, Kosuta D. Pre- operative diagnosis of primary Fallopian tube carci- noma. Gynecol Oncol 1998; 68: 29 – 34
32. Kurjak A, Jukic S, Kupesic S, Babic D. A combined Doppler andmorphopathological study of ovarian tumors. Eur J Obstet Gynecol Reprod Biol 1997; 71: 147 – 50
33. Emoto M, Iwasaki H, Mimura K, Kawarabayashi T, Kikuchi M. Differences in the angiogenesis of benign andmalignant ovarian tumors, demonstratedby analyses of color Doppler ultrasound, immuno- histochemistry, andmicrovessel density. Cancer 1997; 80: 899 – 907
34. Suren A, Osmers R, Kuhn W. Three-dimensional Color Power Angio imaging: a new methodto assess intracervical vascularization in benign andpathologi- cal conditions. Ultrasound Obstet Gynecol 1998; 2: 133 – 8
35. Kurjak A, Kupesic S. Three-dimensional ultrasound andpower Doppler in assessment of uterine and ovarian angiogenesis: a prospective study. Croat Med J 1999; 40: 413 – 20
36. Bourne TH, Campbell S, Steers CV, Whitehead MI, Collins WP. Transvaginal colour flow imaging: a possible new screening technique for ovarian cancer. Br Med J 1989; 299: 1367 – 70
37. Kurjak A, ZaludI, Jurkovic D, Alfirevic Z, Miljan M. Transvaginal color Doppler of the assessment of pelvic circulation. Acta Obstet Gynecol Scand 1989; 68: 131 – 6
38. Fleisher AC, Rodgers WH, Rao BJ, Keppler DM, Worrel JA, Williams L, Jones HW III. Assessment of ovarian tumor vascularity with transvaginal color Doppler sonography. J Ultrasound Med 1991; 10: 563 – 8
39. Kurjak A, ZaludI, Alfirevic Z. Evaluation of adnexal masses with transvaginal color ultrasound. J Ultra- sound Med 1991; 10: 295 – 7
40. Weiner Z, Thaler I, Beck D, Rottem S, Deutsch M, Brandes JM. Differentiating malignant from benign ovarian tumors with transvaginal color flow imaging. Obstet Gynecol 1992; 79: 159 – 62
41. Kurjak A, Schulman H, Sosic A, ZaludI, Shalan H. Transvaginal ultrasound, color flow, and Doppler waveform of the postmenopausal adnexal mass. Obstet Gynecol 1992; 80: 917 – 21
42. Hamper UM, Sheth S, Abbas FM, Rosenshein BN, Aronson D, Kurman JR. Transvaginal color Doppler sonography of adnexal masses: differences in blood flow impedance in benign and malignant lesions. Am J Roentgenol 1993; 160: 1225 – 8
43. Carter J, Saltzman A, Hartenbach E, Fowler J, Carlson L, Twiggs LB. Flow characteristics in benign and malignant gynecologic tumors using transvaginal color flow Doppler. Obstet Gynecol 1994; 83: 125 – 30
44. Hata K, Kata T, Kitao M. Intratumoral peak systolic velocity as a new possible predictor for detection of adnexal malignancy. Am J Obstet Gynecol 1995; 172: 1496 – 1500
45. Kurjak A, Jukic S, Kupesic S, Babic D. A combined Doppler andmorphopathological study of ovarian tumors. Eur J Obstet Gynecol Reprod Biol 1997; 71: 147 – 50
46. Levine D, Feldstein VA, Babcook CJ, Filly RA. Sono- graphy of ovarian masses: poor sensitivity of resistive index for identifying malignant lesions. Am J Roentgenol 1994; 162: 1355 – 9
47. Kurjak A, Kupesic S. Transvaginal color Doppler and pelvic tumor angiogenesis: lessons learnedandfuture challenges. Ultrasound Obstet Gynecol 1995; 6: 145 – 59
48. Kurjak A, Shalan H, Kupesic S, Predanic M, Zalud I, Breyer B, Jukic S. Transvaginal color Doppler sono- graphy in the assessment of pelvic tumor vascularity. Ultrasound Obstet Gynecol 1993; 3: 137 – 54
49. Brown D, Frates M, Laing F, et al. Ovarian masses: can benign andmalignant lesions be differentiatedwith color andpulsedDoppler ultrasound? Radiology 1994; 190: 333 – 6
50. Stein SM, Laifer-Narin S, Johnson MB, Roman LD, Muderspach LI, Tyszka JM, Ralls PW. Differentiation of benign andmalignant adnexal masses: relative value of gray-scale, color Doppler, andspectral Doppler sonography. Am J Roentgenol 1995; 164: 381 – 6
51. Fleischer AC, Cullinan JA, Peery CV, et al. Early detec- tion of ovarian carcinoma with transvaginal color Doppler ultrasonography. Am J Obstet Gynecol 1996; 174: 101 – 6
52. Rubin JM, Bude RO, Carson PL, Bree RI, Adler RS. Power Doppler ultrasound: a potentially useful alter- native to mean frequency-basedcolor Doppler ultra- sound. Radiology 1994; 190: 853 – 6
53. Rubin JM, Adler RS, Fowlkes JB, Spratt S, Pallister JE, Chen JF, Carson PL. Fractional moving bloodvolume: estimation with power Doppler ultrasound. Radiology 1995; 197: 183 – 90
54. Winsberg F. Power Doppler sonography. J Ultrasound Med 1996; 15: 164
55. Papadimitriou A, Kalogirou D, Antonio G, Petridis N, Kalogirou O. Power Doppler ultrasound: a potential useful alternative in diagnosing pelvic pathological conditions. Clin Exp Obstet Gynecol 1996; 23: 229 – 32
56. Burns PN. Harmonic imaging with ultrasoundcon- trast agents. Clin Radiol 1996; 51: 50 – 5
57. Meyerovitz CB, Fleischer AC, Pickens DR, et al. Quantification of tumor vascularity andflow with amplitude color Doppler sonography in an experi- mental mode: preliminary results. J Ultrasound Med 1996; 15: 827
58. Fleischer A, Wojcicki W, Donnely E, et al. Quantified color Doppler sonography of tumor vascularity in an animal model. J Ultrasound Med 1999; 18: 547
59. Bonilla Musoles F, Raga F, Osborne NG. Three- dimensional ultrasound evaluation of ovarian masses. Gynecol Oncol 1995; 59: 129 – 35
60. Merz E. Three-dimensional transvaginal ultrasound in gynecological diagnosis. Ultrasound Obstet Gynecol 1999; 14: 81 – 6
61. Chan L, Lin WM, Verpairojkit B, Hartman D, Reece EA. Evaluation of adnexal masses using three- dimensional ultrasonographic technology: prelimi- nary report. J Ultrasound Med 1997; 16: 349 – 54
62. Weber G, Merz E, Bahlmann F, Macchiella D. Ultra- soundassessment of ovarian tumors: comparison between transvaginal three-dimensional technique andconventional two dimensional vaginal ultrasono- graphy. Ultraschall Med 1997; 18: 26 – 30
63. Riccabona M, Nelson TR, Pretorius DH. Three- dimensional ultrasound: accuracy of distance and vol- ume measurements. Ultrasound Obstet Gynecol 1996; 7: 429 – 34
64. Weber G, Merz E, Bahlman F. Three-dimensional sonography of cystic ovarian tumors. In Merz E, ed. Three-dimensional Ultrasonography and Gynecology. Philadelphia: Lippincott Williams & Wilkins, 1998: 43 – 9
65. Kurjak A, Kupesic S. Ovarian lesions assessedby three-dimensional ultrasound and power Doppler. In Kurjak A, Kupesic S, eds. Clinical Application of Three- Dimensional Sonography. Carnforth, UK: Parthenon Publishing, 2000
66. Kurjak A, Kupesic S, Jacobs I. Preoperative diagnosis of the primary Fallopian tube carcinoma by three- dimensional static and power Doppler sonography. Ultrasound Obstet Gynecol 2000; 15: 246 – 51
67. Kurjak A, Kupesic S, Anic T, Kosuta D. Three- dimensional ultrasoundandpower Doppler improve the diagnosis of ovarian lesions. Gynecol Oncol 2000; 76: 28 – 32
68. Downey BD, Fenster A. Vascular imaging with a three-dimensional power Doppler system. Am J Roentgenol 1995; 165: 665 – 8
69. Kurjak A, Kupesic S, Breyer B, Sparac V, Jukic S. The assessment of ovarian tumor angiogenesis: what does three-dimensional power Doppler add? Ultrasound Obstet Gynecol 1998; 12: 136 – 46
70. Kurjak A, Kupesic S, Sparac V, Kosuta D. Three- dimensional ultrasonographic and power Doppler characterization of ovarian lesions. Ultrasound Obstet Gynecol 2000; 16: 365 – 71
71. Breyer B, Kurjak A. Tumor vascularization Doppler measurements andchaos: what to do? Ultrasound Obstet Gynecol 1995; 5: 209 – 10
72. Fleischer AC, Pairleitner H. Transvaginal Doppler assesses ovarian flow. Diagn Imag 1998; 9: 47
73. Fleischer AC, Pairleitner H. Three-dimensional trans- vaginal color Doppler sonography: current andpoten- tial applications. Med Imag Int 1999; 9: 10 – 13
74. Pairleitner H, Steiner H, Hasenoehrl G, Staudach A. Three-dimensional power Doppler sonography: imaging andquantifying bloodflow andvasculariza- tion. Ultrasound Obstet Gynecol 1999; 14: 139 – 43
75. Ophir J, Parker KJ. Contrast agents in diagnostic ultrasound. Ultrasound Med Biol 1989; 15: 319 – 33
76. Goldberg BB, Merton AD, Forsberg F, Liu J, Rawool N. Color amplitude imaging: preliminary results using vascular sonographic agents. J Ultrasound Med 1990; 15: 127 – 34
77. Kupesic S, Kurjak A. Contrast-enhancedthree- dimensional power Doppler sonography for the differentiation of adnexal masses. Obstet Gynecol 2000; 96: 452 – 8
78. Kurjak A, Kupesic S, Sparac V, Bekavac I. Preoperative evaluation of pelvic tumors by Doppler andthree- dimensional sonography. J Ultrasound Med 2001, in press
79. Boehm T, Folkman J, Browder T, O’Reilly MS. Anti- angiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature (London) 1997; 390: 404 – 7
80. Holmgren L, O’Reilly MS, Folkman J. Dormancy of micrometastases: balancedproliferation andapopto- sis in the presence of angiogenesis suppression. Nature Med 1995; 1: 149 – 53